JAZMINE KENDRICK: Open Payments
NPI 1043943400 · DANVERS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,647 in 137 payments from 17 companies in 2025. Trend: 2023 $922 · 2024 $4,194 · 2025 $2,647
Food & beverage: $2,481Education: $166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $425 |
| UCB, Inc. | 11 | $412 |
| E.R. Squibb & Sons, L.L.C. | 20 | $299 |
| GENZYME CORPORATION | 10 | $253 |
| Lilly USA, LLC | 16 | $222 |
| Janssen Biotech, Inc. | 17 | $189 |
| Incyte Corporation | 10 | $183 |
| Arcutis Biotherapeutics, Inc. | 6 | $152 |
| PFIZER INC. | 6 | $141 |
| Galderma Laboratories, L.P. | 6 | $110 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, Sotyktu, TALTZ, TREMFYA, OPZELURA, CIBINQO.
Industry payments across MA — which companies pay providers there.
